1. Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use. Official Journal of the European Union, L 311, 28/11/2001 p. 0067–0128
2. Directive 2004/27/EC of the European Parliament and of the Council of 31 March 2004, amending Directive 2001/83/EC on the Community code relating to medicinal products for human use. Official Journal of the European Union, L 136, 30/4/2004 p. 34–57
3. Zopf Y, Rabe C, Neubert A et al (2008) Women encounter ADRs more often tan do men. Eur J Clin Pharmacol 64(10):999–1004
4. Lippman A (2006) The inclusion of women in clinical trials: are we asking the right questions? Canada women and health protection. Bureau of women’s health and gender analysis, health canada
5. Vivek HM, Harlan MK, Cary PG (2004) Participation in cancer clinical trials: race-, sex-, and age-based disparities. JAMA 291(22):2720–2726